Logo image of TMDI

TITAN MEDICAL INC (TMDI) Stock Fundamental Analysis

NASDAQ:TMDI - Nasdaq - CA88830X8199 - Common Stock - Currency: USD

0.14  -0.05 (-26.32%)

After market: 0.1241 -0.02 (-11.36%)

Fundamental Rating

1

Taking everything into account, TMDI scores 1 out of 10 in our fundamental rating. TMDI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. TMDI may be in some trouble as it scores bad on both profitability and health. TMDI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TMDI had negative earnings in the past year.
TMDI had a negative operating cash flow in the past year.
TMDI Yearly Net Income VS EBIT VS OCF VS FCFTMDI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -20M -40M

1.2 Ratios

TMDI has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TMDI Yearly ROA, ROE, ROICTMDI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5K 10K

1.3 Margins

TMDI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TMDI Yearly Profit, Operating, Gross MarginsTMDI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

TMDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TMDI has more shares outstanding
The debt/assets ratio for TMDI has been reduced compared to a year ago.
TMDI Yearly Shares OutstandingTMDI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
TMDI Yearly Total Debt VS Total AssetsTMDI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

2.2 Solvency

TMDI has an Altman-Z score of -26.47. This is a bad value and indicates that TMDI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -26.47, TMDI is not doing good in the industry: 89.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.17 indicates that TMDI is not too dependend on debt financing.
TMDI's Debt to Equity ratio of 0.17 is in line compared to the rest of the industry. TMDI outperforms 51.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -26.47
ROIC/WACCN/A
WACC8.45%
TMDI Yearly LT Debt VS Equity VS FCFTMDI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M

2.3 Liquidity

A Current Ratio of 1.41 indicates that TMDI should not have too much problems paying its short term obligations.
TMDI has a worse Current ratio (1.41) than 82.63% of its industry peers.
TMDI has a Quick Ratio of 1.41. This is a normal value and indicates that TMDI is financially healthy and should not expect problems in meeting its short term obligations.
TMDI has a worse Quick ratio (1.41) than 69.01% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
TMDI Yearly Current Assets VS Current LiabilitesTMDI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

TMDI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.21%, which is quite impressive.
Looking at the last year, TMDI shows a very negative growth in Revenue. The Revenue has decreased by -50.23% in the last year.
EPS 1Y (TTM)61.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.64%
Revenue 1Y (TTM)-50.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TMDI Yearly Revenue VS EstimatesTMDI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 5M 10M 15M 20M
TMDI Yearly EPS VS EstimatesTMDI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TMDI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMDI Price Earnings VS Forward Price EarningsTMDI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMDI Per share dataTMDI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TMDI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TITAN MEDICAL INC

NASDAQ:TMDI (3/9/2023, 8:00:01 PM)

After market: 0.1241 -0.02 (-11.36%)

0.14

-0.05 (-26.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)03-22 2023-03-22
Inst Owners0%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.66M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.57
P/FCF N/A
P/OCF N/A
P/B 2.25
P/tB 3.18
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.09
BVpS0.06
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 98.02%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z -26.47
F-Score1
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)630.45%
Cap/Depr(5y)858.27%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-906.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1006.26%
OCF growth 3YN/A
OCF growth 5YN/A